Skip to main content
$2.96Today:- (-)1Y −74.73%

As of Oct 26, 2026 close

Market cap
$4.00M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.52$14.13
Volume (live)
-
Avg. volume (3M)
17.12K

DNA X (SONM) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), DNA X reported total assets of $43.90M and total liabilities of $50.63M. Shareholders' equity was negative at −$6.73M, meaning liabilities exceed assets. Total debt stood at $5.07M against $1.30M in cash and short-term investments, a net debt position of $3.76M.

DNA X Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for DNA X, Inc. (SONM) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents1.305.349.4013.2111.2322.1411.3013.051.58
Cash & Short-Term Investments1.305.349.4013.2111.2322.1411.3013.051.58
Accounts Receivable0.0011.6425.3022.4314.755.1111.4621.4412.16
Inventory0.0010.626.714.105.5411.3419.5321.838.98
Other Current Assets27.6126.821.611.814.161.505.057.554.64
Total Current Assets28.9132.1743.7943.6335.6945.5747.3463.8727.37
Non-Current Assets
Property, Plant & Equipment (Net)0.000.230.070.230.530.841.441.070.72
Long-Term Investments1.240.000.000.000.000.000.000.000.00
Other Non-Current Assets12.317.5712.199.824.871.016.682.412.16
Total Non-Current Assets14.997.5712.2610.055.404.748.123.482.88
Total Assets43.9039.7456.0453.6941.0950.3155.4667.3530.25
Current Liabilities
Accounts Payable4.030.7419.8521.139.478.867.2327.3011.25
Short-Term Debt5.070.000.060.150.150.189.820.303.13
Current Portion of Long-Term Debt---0.150.150.18---
Accrued Liabilities0.700.2512.3010.6911.359.06---
Deferred Revenue0.002.940.640.030.010.010.294.224.68
Other Current Liabilities36.3342.7510.712.709.942.3810.2716.388.97
Total Current Liabilities48.0343.7432.1532.0620.9920.4727.6148.2028.03
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.070.190.3613.217.55
Other Non-Current Liabilities2.601.701.531.581.411.241.960.814.18
Total Non-Current Liabilities2.601.701.531.581.481.432.3214.0211.73
Total Liabilities50.6345.4433.6833.6422.4621.9029.9362.2239.76
Stockholders' Equity
Common Stock1.230.010.000.000.020.010.020.020.00
Retained Earnings-304.27-283.61-249.96-249.87-234.81-196.18-166.25-143.53-144.80
Additional Paid-in Capital296.31277.90272.32269.87253.42224.52191.75148.6454.89
Shares Outstanding1.494.984.314.081.88----
Total Stockholders' Equity-6.73-5.7022.3720.0518.6328.4125.535.13-9.51
Total Liabilities & Equity43.9039.7456.0453.6941.0950.3155.4667.3530.25

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About DNA X Balance Sheet

How much debt does DNA X have?

DNA X had total debt of $5.07M as of Dec 31, 2025, against $1.30M in cash and short-term investments. Total debt was $0.00 a year earlier.

What are DNA X's total assets?

DNA X reported total assets of $43.90M as of Dec 31, 2025, up 10.5% from $39.74M a year earlier. Total liabilities were $50.63M.

What is DNA X's shareholders' equity?

DNA X's shareholders' equity was negative at −$6.73M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition